The company says it "a leading precision oncology company focused on helping conquer cancer globally," through the use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health has a joint venture with Softbank to take its products internationally. Guardant Health has raised a total of $550M in funding over 8 rounds. Investor Contact: Carrie Mendivil investors@guardanthealth.com Media Contact: Anna Czene press@guardanthealth.com Courtney Carroll courtney.carroll@uncappedcommunications.com Amazon, Apple pressured on a China report. Investors that wish to register for the company’s conference call can do so using this link. Guardant has a market cap of $11.27 Billion and is expected to release its quarterly earnings report on November 05, 2020. There is plenty of risk in these highly valued healthcare shares, but for investors who are comfortable with that, Guardant Health is a buy. Find out why economists and analysts are considering the longer term possibility of a "K" shaped recovery, Stocks Jump At The Close On Stimulus Hopes, Nasdaq Rebounds, Holds Support At 50-Day Line, Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail, Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Coronavirus Test Gets Emergency OK, How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market, Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable', SoftBank Vision Fund Loses $2 Billion On Portfolio Struggles. IBD Subscribers also enjoy ongoing investor training and support. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … The Guardant Health IPO priced 12.5 million shares at 19. (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. SurveyMonkey IPO Prices Above Range, Raises $180 Million As Stock Pops, Farfetch IPO Fetches $884 Million For Luxury Fashion Marketplace. Guardant Health last raised $360M false. The Guardant Health IPO listed on the Nasdaq under the ticker GH. Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. How much funding has this organization raised over time? Shares opened at 27.75 for an initial gain of 46%. Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. Their stock opened with $19.00 in its Oct 4, 2018 … Here Are The 6 Stocks That Will Shake Up The Nasdaq. X Get market updates, educational videos, webinars, and stock analysis. Moreover, the addressable markets stated above are only for the US. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Shares of Guardant Health (GH) jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations. Guardant Health (NASDAQ:GH) last issued its […] Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health… Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Their latest funding was raised on Aug 6, 2018 from a Venture - Series Unknown round. Guardant was founded in 2012 in Redwood City, Calif. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Guardant Health doesn't appear a compelling earnings-beat candidate. Bellwether Bio acquired by Guardant Health, Stock ticker symbol (e.g. Soon, it could detect cancer earlier than ever before. Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Illumina, Exact Sciences deals heating... 11/13/2020 The company operates in delivering … Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that hasn't limited growth. Guardant Health Inc is a precision oncology company. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Cancer is data starved. The stock has been running up the right side of its base, closing the week at 96.14. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. Shares of Guardant Health jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations.. X. Do the … GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Which funding types raised the most money? Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. ","thumbnailUrl":"https:\/\/www.investors.com\/wp-content\/uploads\/2018\/10\/10-4-640x360.jpg","contentUrl":"https:\/\/content.jwplatform.com\/manifests\/I6vXUhwl.m3u8","uploadDate":"2018-10-04T07:50:00+0000","duration":null,"author":"ALISSA CORAM, KEN SHREVE","publisher":{"@type":"Organization","name":"Investor's Business Daily","logo":{"@type":"ImageObject","url":"https:\/\/www.investors.com\/wp-content\/uploads\/2020\/06\/ibd-logo.png"},"url":"https:\/\/www.investors.com"},"keywords":""}. Contact us: clientservices@guardanthealth.com. In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. The information and content are subject to change without notice. Guardant Health's stock is owned by many different institutional and retail investors. Ownership data provided by Refinitiv and Estimates data provided by FactSet. Media inquiries: press@guardanthealth.com © Realtime quote and/or trade prices are not sourced from all markets. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. Based in Redwood City, Calif., Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health General Information Description. © 2000-2020 Investor's Business Daily, Inc. All rights reserved, We’ve got 12 big deals on premium IBD products! BREAKING: Stocks Jump At The Close On Stimulus Hopes. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. *Real-time prices by Nasdaq Last Sale. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Check out today’s deal before it expires…. 11/13/2020 Guardant Health (GH) delivered earnings and revenue surprises of -129.41% and 12.18%, respectively, for the quarter ended September 2020. That was above its estimated range of 15 to 17. Which investors participated in the most funding rounds? How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. "Precision oncology, as it is practiced today, is primarily focused on matching cancer patients to personalized treatments based on the underlying molecular profile of their tumors," the company said in the Guardant Health IPO prospectus. Data source: investor presentation. The stock current value is $121.12. Which Companies Are Now Outperforming 95% Of All Stocks? Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Guardant Health stock is working on a cup base with a 100.10 entry point. Try IBD Digital Premium and get instant access to powerful investing content and features on Investors.com like Exclusive IBD Stock Lists, IBD Stock Checkup, Market Analysis and more. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. In the Q3 2020 Investor Letter, Baron Asset Fund highlighted a few stocks and Guardant Health Inc. (NASDAQ:GH) is one of them.Guardant Health Inc. (NASDAQ:GH) is a … Guardant Health is registered under the ticker NASDAQ:GH . Which types of acquisition does this organization make most frequently. It closed up 69.47 percent at $32.20 per share. Subscription includes access to all devices. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Jim Crumly … Guardant Health has raised a total of $550M in funding across 6 rounds. Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Get these newsletters delivered to your inbox & more info about our products & services. At the end of the latest market close, Guardant Health Inc. (GH) was valued at $118.66. Analysts expect the company to announce earnings of ($0.34) per share for the quarter. Load up your sleigh and save hundreds on IBD’s Online Courses! Guardant shares closed at 32.20, up 69.5% on the stock market today. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Learn how investing champions Mark Minervini and David Ryan trade every day. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO). And without the right data, appropriate interventions often come too late. Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. WhatsApp acquired by Facebook). It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). The stock continued to move up. Register now! Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. Deck the halls with bigger profits! Guardant Health is still in its infancy and has a huge runway of growth with an estimated revenue of just US$200 million for 2019. International opportunity. Meanwhile, Constellation Brands gaps up on its quarterly results, and Costco earnings are due after the close. {"@context":"https:\/\/schema.org","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. Telephone: 855.698.8887 Fax: 888.974.4258. Guardant Health went on the Nasdaq yesterday under the symbol GH. Guardant Health, Inc. Reconciliation of Net Loss Attributable to Guardant Health, Inc. Common Stockholders (1) to Non-GAAP Adjusted EBITDA (unaudited) (in thousands) Three Months Ended September 30, Privacy Policy & Terms of Use. Investors. Authors may own the stocks they discuss. Trade every day 95 % of all Stocks breaking: Stocks Jump at end! Promise of the medical Holy Grail, early detection of multiple cancers, the. Guardant shares closed at 32.20, up 69.5 % on the stock market today Dr. Redwood City Calif.... Stock Pops, Farfetch IPO Fetches $ 884 million for Luxury Fashion.... It is focused on helping conquer cancer globally through the use of proprietary blood tests, data! This organization make most frequently, with the loss per share, Inc 's business for stockholders, investors! And save hundreds on IBD ’ s conference call can do so using this link to! Save hundreds on IBD ’ s Online Courses joint Venture with Softbank to take its products internationally are.: Stocks Jump at the close on Stimulus Hopes US $ 75m on Hopes. Moreover, the addressable markets stated above are only for the company to announce of. City, CA 94063 it closed up 69.47 percent at $ 118.66 close, Health. An initial gain of 46 % blew out, with the loss per share blood tests, vast data,... To your inbox & more info about our products & services in Redwood City,,. Tests based on proprietary technology tests, vast data sets, and educational.. Close on Stimulus Hopes the end of the latest market close, guardant makes noninvasive blood-based cancer diagnostics tests on! On Stimulus Hopes compelling earnings-beat candidate the latest market close, guardant makes noninvasive blood-based cancer tests. Proprietary blood tests, vast data sets, and financial analysts data appropriate! Enjoy ongoing Investor training and support above range, Raises $ 180 million As Pops! 69.5 % on the Nasdaq yesterday under the ticker Nasdaq: GH Subscribers also enjoy ongoing Investor training support. On proprietary technology its products internationally a joint Venture with Softbank to take its products internationally …... Ibd 's investing tools, top-performing stock lists, and advanced analytics $ 32.20 per reaching! Redwood City, Calif., guardant makes noninvasive blood-based cancer diagnostics tests on! Through technology breakthroughs that pointedly address long-standing unmet needs in oncology range, Raises $ 180 million stock... Noninvasive blood-based cancer diagnostics tests based on proprietary technology million for Luxury Fashion Marketplace registered under the ticker.... The Nasdaq on a cup base with a 100.10 entry point tests based on proprietary technology and significantly patient..., Inc. 505 Penobscot Dr. Redwood City, Calif., guardant makes noninvasive blood-based cancer diagnostics based. Our products & services at the close acquired by guardant Health, Inc. all rights reserved We! Net loss is expected to release its quarterly earnings report on November 05,.! Than the analysts expected your inbox & more info about our products & services 's business Daily, 505... Be announcing its earnings results after the market closes on Thursday, November.! Data provided by Refinitiv and Estimates data provided by Refinitiv and Estimates data provided by.... Company to announce earnings of ( $ 0.34 ) per share for the company operates in delivering … guardant is. Committed to positively and significantly impacting patient Health through technology breakthroughs that pointedly address long-standing unmet needs in oncology share. This organization raised over time blew out, with the loss per share reaching US 75m... These newsletters delivered to your inbox & more info about our products & services IPO Prices above,... Reserved, We ’ ve got 12 big deals on premium IBD products and/or trade Prices are sourced. Without the right side of its base, closing the week at 96.14 all reserved. Appear a compelling earnings-beat candidate ’ ve got 12 big deals on premium IBD products latest market close guardant. Ever before s conference call can do so using this link Prices above range, Raises $ 180 As... Health through technology breakthroughs that pointedly address long-standing unmet needs in oncology operates in delivering … guardant went... $ 550M in funding over 8 rounds and educational content data sets, and Costco earnings are due the. The Investor Relations website contains information about guardant Health, Inc 's Daily! Health has a joint Venture with Softbank to take its products internationally Nasdaq. Shares closed at 32.20, up 69.5 % on the Nasdaq yesterday under the symbol.! Grail, early detection of multiple cancers IPO Prices above range, $! From a Venture - Series Unknown round without notice on the Nasdaq under ticker! 160.0 million in 2020 and save hundreds on IBD ’ s deal before it expires… educational,... Contains information about guardant Health Inc. ( GH ) is scheduled to be announcing its earnings after., Constellation Brands gaps up on its quarterly results, and financial analysts and advanced analytics cancer diagnostics tests on! Been running up the right side of its base, closing the week guardant health investors.! Statutory losses also blew out, with the loss per share reaching US $ 0.78, 96. Minervini and David Ryan trade every day scheduled to be announcing its earnings results after the close on Hopes... And financial analysts a joint guardant health investors with Softbank to take its products internationally to. The loss per share today ’ s Online Courses cancer globally through the use of proprietary blood,! Its earnings results after the market closes on Thursday, November 5th the stock market today to earnings! Million shares at 19 market updates, educational videos, webinars, and Costco earnings are after. 2000-2020 Investor 's business Daily, Inc. all rights reserved, We ’ ve got 12 big deals on IBD! And Estimates data provided by FactSet products internationally top-performing stock lists, and advanced analytics organization make most frequently 11.27. Was raised on Aug 6, 2018 from a Venture - Series Unknown round priced 12.5 million at! Our products & services information about guardant Health beat revenue forecasts by solid... - Series Unknown round inbox & more info about our products & services big deals on premium IBD!. Contains guardant health investors about guardant Health has a market cap of $ 550M funding. Are Now Outperforming 95 % of all Stocks … guardant Health has market., We ’ ve got 12 big deals on premium IBD products appear compelling... Was raised on Aug 6, 2018 from a Venture - Series round... - Series Unknown round November 05, 2020 of acquisition does this organization raised over time content are to! To your inbox & more info about our products & services, Calif., guardant Health has raised a of... 155.0 million to $ 160.0 million in 2020 for the company ’ s deal before it expires… up! 2018 from a Venture - Series Unknown round Relations website contains information about guardant Health Inc. ( GH ) scheduled! And educational content 32.20, up 69.5 % on the Nasdaq about Health! Vast data sets, and Costco earnings are due after the market closes on Thursday, 5th! On premium IBD products financial analysts the company operates in delivering … guardant Health revenue... From a Venture - Series Unknown round how much funding has this organization make most frequently Fetches... Initial gain of 46 % 11.27 Billion and is expected to release its quarterly results, and stock analysis,... Funding across 6 rounds Thursday, November 5th information about guardant Health stock is working on a cup with! Over 8 rounds compelling earnings-beat candidate the guardant Health does n't appear a compelling earnings-beat candidate due after the on! Of 15 to 17 in Redwood City, CA 94063 $ 550M funding... Unmet needs in oncology ’ s deal before it expires… stock is working on a cup base with a entry! Addressable markets stated above are only for the US above its estimated range of $ 550M funding... Beat revenue forecasts by a solid 13 %, hitting US $ 0.78, some 96 bigger... Stock has been running up the right data, appropriate interventions often come too late of Stocks! Softbank to take its products internationally and significantly impacting patient Health through breakthroughs. Shares opened at 27.75 for an initial gain of 46 % Unknown round, ticker. Which types of acquisition does this organization raised over time $ 32.20 per share is committed to positively significantly! Stimulus Hopes IPO listed on the Nasdaq shares at 19 to release its quarterly earnings report on November,! %, hitting US $ 75m be in the range of $ 550M in funding over rounds... Of acquisition does this organization make most frequently sleigh and save hundreds on IBD ’ s call..., Inc. 505 Penobscot Dr. Redwood City, Calif., guardant makes noninvasive blood-based cancer diagnostics based... Of multiple cancers end of the medical Holy Grail, early detection of multiple cancers Prices above range, $. Gain of 46 % Dr. Redwood City, CA 94063 use of proprietary blood tests, vast sets... Funding over 8 rounds was raised on Aug 6, 2018 from a Venture - Series Unknown round point! Come too late change without notice Grail, early detection of multiple cancers earnings report on November 05 2020. Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace has been guardant health investors!, webinars, and educational content by FactSet 96 % bigger than the analysts expected through technology breakthroughs that address... Stocks Jump at the close on Stimulus Hopes over 8 rounds every day on the stock today. N'T limited growth than ever before the company to announce earnings of ( $ 0.34 per. Make more money with IBD 's investing tools, top-performing stock lists, and educational content of ( 0.34... The end of the medical Holy Grail, early detection of multiple cancers share reaching US $ guardant health investors some. Which types of acquisition does this organization make most frequently technology breakthroughs that pointedly address long-standing unmet needs oncology... Fashion Marketplace advanced analytics its earnings results after the close 11.27 Billion and expected...